ARGX Argenx Year-over-year net earnings per share growth for the last 12 months
The quarterly EPS growth vector demonstrates the asset's dynamics, where the 104.60 level records fresh values. The development of argenx SE (ARGX) relies on a unique antibody platform to combat severe pathologies. Business success is tied to the commercialization of Vyvgart and the approval of new FDA indications. However, risk persists due to revenue concentration in a single drug, which is partially offset by the expansion of its application.
ARGX (argenx.com): analytical breakdowns and indicator data
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
- earnings and market multiples details:
ARGX - Company Profit|Future Profit argenx SE|ARGX - Price to Earnings Multiple|Projected Price to Earnings argenx SE|ARGX - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization argenx N.V.|ARGX - Operating income before deduction of amortization|Net earnings per share (EPS TTM) argenx|ARGX - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth argenx.com|ARGX - Earnings growth in current year|Net earnings per share growth forecast for next year argenx SE
- company sales and revenue statistics:
Summary company analytics:argenx N.V. - ARGX
This indicator measures the rate of change in earnings per share, neutralizing the time lag between quarterly reports. For argenx SE (ARGX), this metric reflects financial efficiency given the full outsourcing of production and testing to third-party contractors. By analyzing the quarterly EPS evolution, an investor can discern the actual profitability of the R&D model. Rising values confirm the optimization of outsourcing costs, which guarantees long-term capital stability.
Competitors of argenx SE
BioNTech Pharma (BNTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Abivax|Year-over-year net earnings per share growth for the last 12 months ADMA|Quarterly EPS earnings growth protagonist-inc.com|Year-over-year earnings per share growth for the last twelve months Immunovant Corp (IMVT)|Kiniksa - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth GRFS (grifols.com)|Adaptive Biotechnologies Corp (ADPT) - Earnings per share growth in annualized terms for the last twelve months|celldex.com - Quarterly EPS earnings growth|AUPH - Quarterly EPS earnings growth|BCRX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Vera Therapeutics Inc (VERA)|DNTH (Dianthus Therapeutics Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Pharvaris Pharma|Quarterly EPS earnings growth ABCL|TRML (tourmalinebio.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PGEN (Precigen Inc)|PHAR - Year-over-year net earnings per share growth for the last 12 months|NKTR - Year-over-year earnings per share growth for the last twelve months|UPB - Quarterly EPS earnings growth|ZBIO: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Immunome, Inc.|Year-over-year earnings per share growth for the last twelve months Gossamer Bio|Quarterly EPS earnings growth KalVista Pharmaceuticals Inc|Year-over-year net earnings per share growth for the last 12 months SEPN (Septerna Corp)|PVLA (Pieris Pharmaceuticals Inc) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth SVRA (savarapharma.com)|Year-over-year earnings per one share growth for the last 12 months RIGL|ANAB: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ATXS (Astria Therapeutics, Inc.)|ENGN: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months RAPT Therapeutics, Inc. (RAPT)|Year-over-year earnings per share growth for the last twelve months aerovatetx.com|Quarterly EPS earnings growth aclaristx.com|Year-over-year earnings per share growth for the last twelve months Kyverna Therapeutics (KYTX)|Year-over-year net earnings per share change for the last twelve months Tiziana Life Sciences Ltd|Quarterly EPS earnings growth CABA (Cabaletta Bio Inc)|VTYX: Year-over-year earnings per share growth for the last 12 months|Theratechnologies, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Avalo Therapeutics, Inc AVTX|ELDN (Eledon Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|Agenus Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Climb Bio|Quarterly EPS earnings growth Zura Bio Ltd|Year-over-year net earnings per share growth for the last 12 months ATYR (aTyr Pharma Inc)|Year-over-year net earnings per share change for the last twelve months Adagene Inc|Year-over-year earnings per share growth for the last twelve months ImageneBio Inc IMA|Year-over-year earnings per share growth rate for the last twelve months STTK (shattucklabs.com)|EQ: Year-over-year net earnings per share growth for the last 12 months|CNTB: Year-over-year earnings per share growth for the last twelve months|IMUX: Quarterly EPS earnings growth|Atara Biotherapeutics (ATRA) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months IFRX|Quarterly EPS earnings growth X4 Pharmaceuticals Inc.|Year-over-year earnings per share growth for the last twelve months Adicet Bio Inc. (ACET)|Year-over-year net earnings per share growth for the last 12 months Celularity CELU|Quarterly EPS earnings growth INMB (INmune Bio Corporation)|Year-over-year net earnings per share change for the last twelve months Barinthus Biotherapeutics (BRNS)|KZR - Year-over-year earnings per share growth for the last twelve months|SABS - Quarterly EPS earnings growth|Akari Therapeutics, Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Enlivex Therapeutics, Ltd. (ENLV) - Quarterly EPS earnings growth|QTTB (Q32 Bio Inc) - Quarterly EPS earnings growth|geovax.com (GOVX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months EDSA (Edesa Biotech)|Year-over-year net earnings per share change for the last twelve months iBio Inc|Quarterly EPS earnings growth CARM (Carisma Therapeutics Inc)|Year-over-year earnings per one share growth for the last 12 months XTLB|BOLT: Year-over-year net earnings per share growth for the last 12 months|HCW Biologics (HCWB) - Year-over-year net earnings per share growth for the last 12 months|Aptevo (APVO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months AIM ImmunoTech|Year-over-year net earnings per share growth for the last 12 months ADTX|GRI Bio Corporation (GRI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months XRTX (XORTX Therapeutics Inc.)|Vyome Holdings Inc - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences Inc REVB|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI: Year-over-year earnings per share growth for the last twelve months|AFMD: Quarterly EPS earnings growth|Allakos Inc - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|IGM Biosciences, Inc. (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iteostherapeutics.com (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|THRD: Year-over-year earnings per share growth for the last 12 months
